Avazyme posted this:Food safety, quality, authenticity and consulting servicesAvazyme offers agile and custom problem solving services to the food industry through the application of biological and chemical analytics. Differentiated from larger CROs that offer a rigid standardized menu of services, Avazyme is focused first on agile problem solving. Avazyme has state-of-the-art instrumentation and methodologies. Problem solving is applied to food safety, quality, authenticity and GMO testing. Avazyme also offers consulting in food regulatory science, Maximum Residue Levels (MRLs), import tolerances and food safety, quality and secondary standards, nutritional labeling, authenticity and GMO analysis. Consulting in new assay development, validation and certificate of analysis is also offered. Differentiated from larger CROs, Avazyme offers nimble, rapid and custom analytical method development and validation. Offers include development of laboratory and point of use assays. Avazyme offers organizations Independent Lab Validation (ILV). Avazyme is BSL2, EPA GLP, FDA GLP compliant and will work with companies requiring GMP and ISO17025 standards.
Yissum - Research Development Company of the Hebrew University posted this:Nanopatterned Surfaces for Triggered Delivery of Biologically Active MoleculesNanopatterned Surfaces for Triggered Delivery of Biologically Active Molecules Project ID : 12-2018-5686
Yissum - Research Development Company of the Hebrew University posted this:Early Detection and Personalized Treatment of Breast Cancer, Using Comparative GenomicsUsing cutting-edge comparative genomics, data integration, and machine learning, the researchers will develop a comprehensive gene panel that can identify increased risk of breast cancer and offer personalized treatment options based on PARP inhibitors. Project ID : 6-2018-6690
Yissum - Research Development Company of the Hebrew University posted this:Using Chlorella Ohadii Algae Genes to Improve Plant Resistance to PhotodamageA photo damage resistant transgenic plant. Project ID : 8-2018-5702
Yissum - Research Development Company of the Hebrew University posted this:Self-Operated App for Classifform-control ication, Diagnosis, and Rehabilitation of Language Disorders (Aphasia)Self-Operated App for Classification, Diagnosis, and Rehabilitation of Language Disorders (Aphasia) Project ID : 19-2019-6710
Technology Transfer OfficeView Profile
Fundación para la Investigación Biosanitaria de Andalucía Oriental (FIBAO) posted this:Predict method of Pregnant Gestational ageDespite the great effort among all sectors of health, the rate of PD remains the "big problem" for obstetricians, neonatologists and other medical specialists, both the difficulties related to the care and complications of those born and their prognosis. long-term. Because PD, in addition to increasing perinatal morbidity and mortality, causes neurological damage and affects development in newborns, there is a great need to identify women at risk of preterm delivery and includes the mechanisms that culminate in PP. method that serves to predict, with clinical and analytical variables, the week of gestation in which delivery will occur.
Centre Technology Transfer CITTRU posted this:Method for conjugation of biomolecules and its new useThe subject of the offer is a novel method for conjugation of free thiol group(s) containing biomolecules comprising a biomolecule reaction with a gold-donor agent in which a -S-Au-S- bond is formed. Specifically, the method leads to a complex formation that is a protein cage. The new method comprises following steps: (i) biomolecules preparation, (ii) conjugation of biomolecules by reaction of biomolecules with gold-donor and (iii) purification of conjugation product.
Centre Technology Transfer CITTRU posted this:In vivo delivery system of the DNA modifying enzymesThe subject of the offer is a new method of in vivo genome editing with the use of hybrid nucleases, such as ZFN, TALEN and the CRISPR/Cas9 system, delivered to target cells by EVs derived from stem cells in serum-free conditions and defined as the RNA-containing vesicles expressing stem cells surface markers: CD90, CD105, CD147, CD309 (in more than 20% of RNA-positive events) and lack of expression CD45.
Yissum - Research Development Company of the Hebrew University posted this:A Novel Synthetic Peptide to Inhibit Biofilm Creation of Bacillus cereus bacteriaa novel synthetic peptide, for the inhibition of bacterial cell-cell communications (quorum sensing, QS), in order to inhibit virulent gene expression. Specifically, for Bacillus cereus bacteria Project ID : 23-2018-4670
Laijo Jose posted this:
Manager-Tech Transfer at Centre For Future (CFF)
Yissum - Research Development Company of the Hebrew University posted this:Computational Tool for the Design of a Personalized Protocol for Cancer Therapy, Based on Protein ExpressionCluster7 Cluster8 From big data analysis to personalized medicine in cancer: towards the development of a computational tool for the rational design of patient-specific combination therapy. Project ID : 10-2016-4322
Yissum - Research Development Company of the Hebrew University posted this:Anti-Infectious Coating for Dental ImplantsSelf-assembly of fluorine-capped moieties for prevention of biofilms Keywords: self-assembly, dental, dentistry, biolfilm, disruption Project ID : 9-2015-3142
Yissum - Research Development Company of the Hebrew University posted this:Identify Drug Candidates for Liposomal Reformulation Using an AlgorithmModeling structural drug descriptors for loading and leakage properties of liposomal drugs for the rational identification of new liposomal drug candidates. OLD: Algorithm to Identify Drug Candidates for Liposomal Reformulation Project ID : 6-2016-4303
Yissum - Research Development Company of the Hebrew University posted this:Develop Herbicide-Resistant Plants by Engineering Known EnzymesCluster11 OLD: Engineering Known Enzymes for the Development of Herbicide-Resistant Plants Project ID : 8-2018-4605